Similarly, while both Δ9-THC and CP-55,940 act as full agonists at both GPR18 and GPR55 [67,68,70], both of these cannabinoid ligands are unable to bind non-canonical CBRs expressed in all the cancer cells investigated. This evidence concerns the gene GPR18 and cancer.